Aster Capital Management (Difc) LTD Vir Biotechnology, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 34,380 shares of VIR stock, worth $331,767. This represents 0.1% of its overall portfolio holdings.
Number of Shares
34,380
Previous 178
19214.61%
Holding current value
$331,767
Previous $1.33 Million
18830.91%
% of portfolio
0.1%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VIR
# of Institutions
228Shares Held
88.4MCall Options Held
571KPut Options Held
216K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$161 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$159 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$127 Million0.0% of portfolio
-
State Street Corp Boston, MA5.07MShares$49 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.22MShares$31.1 Million0.64% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.28B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...